Multiple Benefits With New Diabetes Drugs

VIENNA (MedPage Today) -- The newest class of diabetes medications, the SGLT2 inhibitors, were good at controlling HbA1c and offered additional benefits of weight loss and greater reductions in blood pressure, researchers said here.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news